Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Cerchione

Showing results (51-60 of 127) with videos related to

Pageof 13
Sort By:
Clinical Case Reports|April 12, 2017
A case of efficacy of bendamustine in heavily pretreated multiple myeloma, refractory to pomalidomideClaudio Cerchione, Davide Nappi, Maria Di Perna, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 5, 2016
Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experienceClaudio Cerchione, Amalia De Renzo, Maria Di Perna, et al.
Clinical Nuclear Medicine|January 22, 2015
18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative studyRosa Fonti, Leonardo Pace, Claudio Cerchione, et al.
Translational Oncology|December 5, 2021
Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients?Roberta Maltoni, Sara Ravaioli, Giuseppe Bronte, et al.
Diagnostics (Basel, Switzerland)|November 13, 2025
Qualitative and Quantitative Inter-Observer Agreement of Multiparametric Whole-Body MRI in Staging and Follow-Up of Myeloma PatientsAlice Rossi, Arrigo Cattabriga, Andrea Prochowski Iamurri, et al.
Cells|December 16, 2020
Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma ModelBeatrice Anna Zannetti, Angelo Corso Faini, Evita Massari, et al.
Minerva Medica|September 21, 2020
CPX-351 daunorubicin-cytarabine liposome: a novel formulation to treat patients with newly diagnosed secondary acute myeloid leukemiaAlessandro Cafaro, Maria B Giannini, Paolo Silimbani, et al.
Minerva Medica|September 21, 2020
Tagraxofusp and anti-CD123 in blastic plasmacytoid dendritic cell neoplasm: a new hopeDelia Cangini, Paolo Silimbani, Alessandro Cafaro, et al.
Minerva Medica|September 21, 2020
Gemtuzumab ozogamicin in acute myeloid leukemia: past, present and futureMichele Gottardi, Alessandra Sperotto, Andrea Ghelli Luserna Di Rorà, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 31, 2021
Patients with multiple myeloma referred for palliative care consultation: from retrospective analysis to future directions to improve clinical outcomesMaria Caterina Pallotti, Romina Rossi, Emanuela Scarpi, et al.
Pageof 13

Showing results (51-60 of 127) with videos related to

Sort By:
Pageof 13
Clinical Case Reports|April 12, 2017
A case of efficacy of bendamustine in heavily pretreated multiple myeloma, refractory to pomalidomideClaudio Cerchione, Davide Nappi, Maria Di Perna, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 5, 2016
Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experienceClaudio Cerchione, Amalia De Renzo, Maria Di Perna, et al.
Clinical Nuclear Medicine|January 22, 2015
18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative studyRosa Fonti, Leonardo Pace, Claudio Cerchione, et al.
Translational Oncology|December 5, 2021
Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients?Roberta Maltoni, Sara Ravaioli, Giuseppe Bronte, et al.
Diagnostics (Basel, Switzerland)|November 13, 2025
Qualitative and Quantitative Inter-Observer Agreement of Multiparametric Whole-Body MRI in Staging and Follow-Up of Myeloma PatientsAlice Rossi, Arrigo Cattabriga, Andrea Prochowski Iamurri, et al.
Cells|December 16, 2020
Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma ModelBeatrice Anna Zannetti, Angelo Corso Faini, Evita Massari, et al.
Minerva Medica|September 21, 2020
CPX-351 daunorubicin-cytarabine liposome: a novel formulation to treat patients with newly diagnosed secondary acute myeloid leukemiaAlessandro Cafaro, Maria B Giannini, Paolo Silimbani, et al.
Minerva Medica|September 21, 2020
Tagraxofusp and anti-CD123 in blastic plasmacytoid dendritic cell neoplasm: a new hopeDelia Cangini, Paolo Silimbani, Alessandro Cafaro, et al.
Minerva Medica|September 21, 2020
Gemtuzumab ozogamicin in acute myeloid leukemia: past, present and futureMichele Gottardi, Alessandra Sperotto, Andrea Ghelli Luserna Di Rorà, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 31, 2021
Patients with multiple myeloma referred for palliative care consultation: from retrospective analysis to future directions to improve clinical outcomesMaria Caterina Pallotti, Romina Rossi, Emanuela Scarpi, et al.
Pageof 13